Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 75
- +4 vs. Q4 2022
- Portfolio value
- $2.04B
- +$177.5M (+9.6%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RXDXPrometheus Biosciences, Inc. | COM | 1,897,500 | $203.6M | 10.0% | 00.0% | Unchanged | History |
| RETAReata Pharmaceuticals Inc | CL A | 1,230,004 | $111.8M | 5.5% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $107.8M | 5.3% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 775,000 | $106.8M | 5.2% | +775,000 | New | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,576,000 | $104.0M | 5.1% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $103.6M | 5.1% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 4,684,264 | $101.5M | 5.0% | +700,000+17.6% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,421,541 | $88.1M | 4.3% | 00.0% | Unchanged | History |
| MRTXMirati Therapeutics, Inc. | COM | 2,000,000 | $74.4M | 3.7% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $73.9M | 3.6% | 00.0% | Unchanged | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 2,084,000 | $61.1M | 3.0% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $45.9M | 2.3% | 00.0% | Unchanged | History |
| SGENSeagen Inc. | COM | 200,000 | $40.5M | 2.0% | +200,000 | New | History |
| RLAYRelay Therapeutics, Inc. | COM | 2,169,132 | $35.7M | 1.8% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $35.0M | 1.7% | 00.0% | Unchanged | History |
| VKTXViking Therapeutics, Inc. | COM | 2,000,000 | $33.3M | 1.6% | +500,000+33.3% | Added | History |
| ETNB89bio, Inc. | COM | 2,100,000 | $32.0M | 1.6% | +700,000+50.0% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 831,495 | $31.8M | 1.6% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,210,192 | $31.6M | 1.6% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $30.2M | 1.5% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,154,058 | $29.3M | 1.4% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 850,000 | $28.5M | 1.4% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $28.3M | 1.4% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 7,123,642 | $28.1M | 1.4% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,432,200 | $26.1M | 1.3% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $25.8M | 1.3% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $25.1M | 1.2% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 400,000 | $24.7M | 1.2% | 00.0% | Unchanged | History |
| Bellus Health Inc New07987C204 | COM NEW | 3,200,000 | $23.0M | 1.1% | 00.0% | Unchanged | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 3,705,133 | $22.6M | 1.1% | +2,200,000+146.2% | Added | History |
| EXELExelixis, Inc. | COM | 1,150,000 | $22.3M | 1.1% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $21.5M | 1.1% | 00.0% | Unchanged | History |
| ISEEIVERIC bio, Inc. | COM | 825,000 | $20.1M | 1.0% | 00.0% | Unchanged | History |
| Rain Oncology Inc.75082Q105 | COM | 2,147,212 | $18.8M | 0.9% | 00.0% | Unchanged | – |
| PNTPOINT Biopharma Global Inc. | COM | 2,500,000 | $18.2M | 0.9% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $17.2M | 0.8% | 00.0% | Unchanged | – |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $15.9M | 0.8% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 710,644 | $15.6M | 0.8% | +710,644 | New | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 3,163,795 | $15.1M | 0.7% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 300,000 | $14.5M | 0.7% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,650,000 | $13.0M | 0.6% | +1,650,000 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $11.0M | 0.5% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $10.9M | 0.5% | 00.0% | Unchanged | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 95,000 | $10.2M | 0.5% | 00.0% | Unchanged | History |
| MORFMorphic Holding, Inc. | COM | 200,000 | $7.53M | 0.4% | +200,000 | New | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,054,000 | $6.01M | 0.3% | 00.0% | Unchanged | History |
| COGTCogent Biosciences, Inc. | COM | 525,000 | $5.67M | 0.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 300,000 | $5.50M | 0.3% | +300,000 | New | History |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $5.11M | 0.3% | 00.0% | Unchanged | – |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 250,000 | $4.89M | 0.2% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,251,137 | $4.82M | 0.2% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 459,836 | $4.69M | 0.2% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 3,284,072 | $4.57M | 0.2% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 540,000 | $4.47M | 0.2% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 3,336,928 | $4.21M | 0.2% | 00.0% | Unchanged | History |
| PRLDPrelude Therapeutics Inc | COM | 699,047 | $3.98M | 0.2% | +699,047 | New | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,014,858 | $3.81M | 0.2% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 510,000 | $3.19M | 0.2% | 00.0% | Unchanged | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 350,000 | $3.11M | 0.2% | −65,000−15.7% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 500,000 | $2.85M | 0.1% | −750,000−60.0% | Reduced | History |
| IRONDisc Medicine, Inc. | COM | 130,000 | $2.75M | 0.1% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 698,861 | $2.75M | 0.1% | 00.0% | Unchanged | History |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $2.51M | 0.1% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 1,450,000 | $2.45M | 0.1% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 570,417 | $2.35M | 0.1% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $2.04M | 0.1% | 00.0% | Unchanged | History |
| EQRXEQRx, Inc. | COM | 1,000,000 | $1.94M | 0.1% | 00.0% | Unchanged | History |
| BCABBioAtla, Inc. | COM | 686,347 | $1.84M | 0.1% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | 2,250,000 | $1.59M | 0.1% | 00.0% | Unchanged | History |
| TCRTAlaunos Therapeutics, Inc. | COM | 1,500,000 | $945.0K | <0.1% | 00.0% | Unchanged | History |
| LITSLite Strategy, Inc. | COM NEW | 2,913,091 | $667.0K | <0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $655.0K | <0.1% | 00.0% | Unchanged | History |
| VERUVeru Inc. | COM | 347,300 | $403.0K | <0.1% | 00.0% | Unchanged | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $32.0K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $4.00K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q4 2022 (3)
Positions held at the end of Q4 2022 that are gone from this filing.